REPORTS

Let’s Pullulate and Expand Your Business

Vaccines Market - Global Professional Analysis and Forecast to 2026

Oct 16, 2019  |  194 PAGES  |  REPORT CODE: CMM212493
  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • INDUSTRY COVERAGE

The worldwide Vaccines market was valued at XX.0 Million US$ in 2018 and is projected to reach XX.0 Million US$ by 2026, at a CAGR (Compound Annual Growth Rate) of 15.1% during the forecast period.

This report presents the market size and development trends by detailing the Vaccines market revenue, market share and growth rate from 2015-2026, and it gives a thorough analysis by various product types, applications, regions, and main participants. The market conditions (2015-2019), corporate competition pattern, corporate SWOT analysis are elaborated, and other qualitative analyses like market dynamics, market penetration, market business environment analyses, the regional regulatory scenario in the Vaccines market will be shown in this report. In short, this report will comprehensively reveal the characteristics of Vaccines industry and will help you to build a panoramic view of the industrial development.

Vaccines Market, By Type:

  • Live

  • Conjugate

  • Toxoid

  • Recombinant

  • Others

Vaccines Market, By Application:

  • Pediatric

  • Adult

  • Others

Some of the leading players are as follows:

  • Jintan

  • Kangtai

  • Hissen

  • J&J(Crucell)

  • Novartis(GSK)

  • Sanofi

  • Hualan

  • MedImmune

  • CSL

  • Pfizer

  • Merck

  • China National Biotec

  • Tiantan

  • GSK

Geographically, Major regions are analyzed in details are as follows:

  • North America

  • Europe

  • Asia Pacific

  • Latin America

  • Middle East & Africa

Table of Contents

1 Methodology and Scope

  • 1.1 Market Segmentation & Scope

    • 1.1.1 Technology Type

    • 1.1.2 Product

    • 1.1.3 Application

    • 1.1.4 Regional scope

    • 1.1.5 Estimates and forecast timeline

  • 1.2 Research Methodology

  • 1.3 Information Procurement

    • 1.3.1 Purchased database

    • 1.3.2 Internal database

    • 1.3.3 Secondary sources

    • 1.3.4 Primary research

    • 1.3.5 Details of primary research

  • 1.4 Information or Data Analysis

    • 1.4.1 Data analysis models

  • 1.5 Market Formulation & Validation

  • 1.6 Model Details

    • 1.6.1 Commodity flow analysis

    • 1.6.2 Volume price analysis

  • 1.7 List of Secondary Sources

  • 1.8 List of Abbreviations

2 Executive Summary

  • 2.1 Market Outlook

  • 2.2 Segment Outlook

3 Market Variables, Trends, & Scope

  • 3.1 Market Lineage Outlook

  • 3.1.1 Parent market outlook

    • 3.1.2 Ancillary market outlook

  • 3.2 Market Segmentation

    • 3.2.1 Analysis

  • 3.3 Market Dynamics

    • 3.3.1 Market driver analysis

    • 3.3.2 Market restraint analysis

    • 3.3.3 Industry opportunities

  • 3.4 Penetration & Growth Prospect Mapping

    • 3.4.1 Penetration & growth prospect mapping analysis

  • 3.5 Business Environment Analysis Tools

    • 3.5.1 Porter's five forces analysis

    • 3.5.2 PESTLE analysis

    • 3.5.3 Major deals & strategic alliances analysis

4 Vaccines Market: Technology Type Analysis

  • 4.1 Vaccines Technology Type Market Share Analysis, 2018 & 2026

  • 4.2 Vaccines Technology Type Market: Segment Dashboard

  • 4.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Technology Type Segment

    • 4.3.1 Live

    • 4.3.2 Conjugate

    • 4.3.3 Toxoid

    • 4.3.4 Recombinant

    • 4.3.5 Others

5 Vaccines Market: Product Analysis

  • 5.1 Vaccines Product Market Share Analysis, 2018 & 2026

  • 5.2 Vaccines Product Market: Segment Dashboard

  • 5.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Product Segment

6 Vaccines Market: Application Analysis

  • 6.1 Vaccines Application Market Share Analysis, 2018 & 2026

  • 6.2 Vaccines Application Market: Segment Dashboard

  • 6.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Application Segment

    • 6.3.1 Pediatric

    • 6.3.2 Adult

    • 6.3.3 Others

7 Vaccines Market: Regional Analysis

  • 7.1 Vaccines Regional Market Share Analysis, 2018 & 2026

  • 7.2 Vaccines Regional Market: Segment Dashboard

  • 7.3 Regional Market Snapshot (Market Size, CAGR, Top Countries)

  • 7.4 List of Players at Regional Level

    • 7.4.1 North America

    • 7.4.2 Europe

    • 7.4.3 Asia Pacific

  • 7.5 SWOT Analysis, by Factor (Political & Legal, Economic and Technological)

    • 7.5.1 North America

    • 7.5.2 Europe

    • 7.5.3 Asia Pacific

    • 7.5.4 Latin America

    • 7.5.5 MEA

  • 7.6 Market Size & Forecasts, and Trend Analysis, 2015 to 2026

    • 7.6.1 North America

    • 7.6.2 Europe

    • 7.6.3 Asia Pacific

    • 7.6.4 Latin America

    • 7.6.5 Middle East & Africa

8 Competitive Analysis

  • 8.1 Recent Developments & Impact Analysis, by Key Market Participants

  • 8.2 Strategic Framework/Competition Categorization (Key innovators, Market leaders, Emerging players)

  • 8.3 Vendor Landscape

    • 8.3.1 Company market position analysis (Geographic presence, service portfolio, strategic initiatives)

9 Company Profiles

  • 9.1 Jintan

    • 9.1.1 Jintan Company overview

    • 9.1.2 Financial performance

    • 9.1.3 Product benchmarking

    • 9.1.4 Strategic initiatives

    • 9.1.5 SWOT analysis

  • 9.2 Kangtai

    • 9.2.1 Kangtai Company overview

    • 9.2.2 Financial performance

    • 9.2.3 Product benchmarking

    • 9.2.4 Strategic initiatives

    • 9.2.5 SWOT analysis

  • 9.3 Hissen

    • 9.3.1 Hissen Company overview

    • 9.3.2 Financial performance

    • 9.3.3 Product benchmarking

    • 9.3.4 Strategic initiatives

    • 9.3.5 SWOT analysis

  • 9.4 J&J(Crucell)

    • 9.4.1 J&J(Crucell) Company overview

    • 9.4.2 Financial performance

    • 9.4.3 Product benchmarking

    • 9.4.4 Strategic initiatives

    • 9.4.5 SWOT analysis

  • 9.5 Novartis(GSK)

    • 9.5.1 Novartis(GSK) Company overview

    • 9.5.2 Financial performance

    • 9.5.3 Product benchmarking

    • 9.5.4 Strategic initiatives

    • 9.5.5 SWOT analysis

  • 9.6 Sanofi

    • 9.6.1 Sanofi Company overview

    • 9.6.2 Financial performance

    • 9.6.3 Product benchmarking

    • 9.6.4 Strategic initiatives

    • 9.6.5 SWOT analysis

  • 9.7 Hualan

    • 9.7.1 Hualan Company overview

    • 9.7.2 Financial performance

    • 9.7.3 Product benchmarking

    • 9.7.4 Strategic initiatives

    • 9.7.5 SWOT analysis

  • 9.8 MedImmune

    • 9.8.1 MedImmune Company overview

    • 9.8.2 Financial performance

    • 9.8.3 Product benchmarking

    • 9.8.4 Strategic initiatives

    • 9.8.5 SWOT analysis

  • 9.9 CSL

    • 9.9.1 CSL Company overview

    • 9.9.2 Financial performance

    • 9.9.3 Product benchmarking

    • 9.9.4 Strategic initiatives

    • 9.9.5 SWOT analysis

  • 9.10 Pfizer

    • 9.10.1 Pfizer Company overview

    • 9.10.2 Financial performance

    • 9.10.3 Product benchmarking

    • 9.10.4 Strategic initiatives

    • 9.10.5 SWOT analysis

  • 9.11 Merck

    • 9.11.1 Merck Company overview

    • 9.11.2 Financial performance

    • 9.11.3 Product benchmarking

    • 9.11.4 Strategic initiatives

    • 9.11.5 SWOT analysis

  • 9.12 China National Biotec

    • 9.12.1 China National Biotec Company overview

    • 9.12.2 Financial performance

    • 9.12.3 Product benchmarking

    • 9.12.4 Strategic initiatives

    • 9.12.5 SWOT analysis

  • 9.13 Tiantan

    • 9.13.1 Tiantan Company overview

    • 9.13.2 Financial performance

    • 9.13.3 Product benchmarking

    • 9.13.4 Strategic initiatives

    • 9.13.5 SWOT analysis

  • 9.14 GSK

    • 9.14.1 GSK Company overview

    • 9.14.2 Financial performance

    • 9.14.3 Product benchmarking

    • 9.14.4 Strategic initiatives

    • 9.14.5 SWOT analysis

 

The List of Tables and Figures (Totals 109 Figures and 148 Tables)

  • Figure Live Vaccines market, 2015 - 2026 (USD Million)

  • Figure Conjugate Vaccines market, 2015 - 2026 (USD Million)

  • Figure Toxoid Vaccines market, 2015 - 2026 (USD Million)

  • Figure Recombinant Vaccines market, 2015 - 2026 (USD Million)

  • Figure Others Vaccines market, 2015 - 2026 (USD Million)

  • Figure Pediatric market, 2015 - 2026 (USD Million)

  • Figure Adult market, 2015 - 2026 (USD Million)

  • Figure Others market, 2015 - 2026 (USD Million)

  • Table List of players in North America

  • Table List of players in Europe

  • Table List of players in Asia Pacific

  • Table SWOT analysis

  • Table North America Vaccines market, by country, 2015 - 2026 (USD Million)

  • Table North America Vaccines market, by type, 2015 - 2026 (USD Million)

  • Table North America Vaccines market, by product, 2015 - 2026 (USD Million)

  • Table North America Vaccines market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table U.S. Vaccines market, by type, 2015 - 2026 (USD Million)

  • Table U.S. Vaccines market, by product, 2015 - 2026 (USD Million)

  • Table U.S. Vaccines market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Canada Vaccines market, by type, 2015 - 2026 (USD Million)

  • Table Canada Vaccines market, by product, 2015 - 2026 (USD Million)

  • Table Canada Vaccines market, by application, 2015 - 2026 (USD Million)

  • Table Europe Vaccines market, by country, 2015 - 2026 (USD Million)

  • Table Europe Vaccines market, by type, 2015 - 2026 (USD Million)

  • Table Europe Vaccines market, by product, 2015 - 2026 (USD Million)

  • Table Europe Vaccines market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table U.K. Vaccines market, by type, 2015 - 2026 (USD Million)

  • Table U.K. Vaccines market, by product, 2015 - 2026 (USD Million)

  • Table U.K. Vaccines market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Germany Vaccines market, by type, 2015 - 2026 (USD Million)

  • Table Germany Vaccines market, by product, 2015 - 2026 (USD Million)

  • Table Germany Vaccines market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table France Vaccines market, by type, 2015 - 2026 (USD Million)

  • Table France Vaccines market, by product, 2015 - 2026 (USD Million)

  • Table France Vaccines market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Italy Vaccines market, by type, 2015 - 2026 (USD Million)

  • Table Italy Vaccines market, by product, 2015 - 2026 (USD Million)

  • Table Italy Vaccines market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Spain Vaccines market, by type, 2015 - 2026 (USD Million)

  • Table Spain Vaccines market, by product, 2015 - 2026 (USD Million)

  • Table Spain Vaccines market, by application, 2015 - 2026 (USD Million)

  • Table Asia Pacific Vaccines market, by country, 2015 - 2026 (USD Million)

  • Table Asia Pacific Vaccines market, by type, 2015 - 2026 (USD Million)

  • Table Asia Pacific Vaccines market, by product, 2015 - 2026 (USD Million)

  • Table Asia Pacific Vaccines market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table China Vaccines market, by type, 2015 - 2026 (USD Million)

  • Table China Vaccines market, by product, 2015 - 2026 (USD Million)

  • Table China Vaccines market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Japan Vaccines market, by type, 2015 - 2026 (USD Million)

  • Table Japan Vaccines market, by product, 2015 - 2026 (USD Million)

  • Table Japan Vaccines market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table India Vaccines market, by type, 2015 - 2026 (USD Million)

  • Table India Vaccines market, by product, 2015 - 2026 (USD Million)

  • Table India Vaccines market, by application, 2015 - 2026 (USD Million)

  • Table Latin America Vaccines market, by country, 2015 - 2026 (USD Million)

  • Table Latin America Vaccines market, by type, 2015 - 2026 (USD Million)

  • Table Latin America Vaccines market, by product, 2015 - 2026 (USD Million)

  • Table Latin America Vaccines market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Brazil Vaccines market, by type, 2015 - 2026 (USD Million)

  • Table Brazil Vaccines market, by product, 2015 - 2026 (USD Million)

  • Table Brazil Vaccines market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Mexico Vaccines market, by type, 2015 - 2026 (USD Million)

  • Table Mexico Vaccines market, by product, 2015 - 2026 (USD Million)

  • Table Mexico Vaccines market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Argentina Vaccines market, by type, 2015 - 2026 (USD Million)

  • Table Argentina Vaccines market, by product, 2015 - 2026 (USD Million)

  • Table Argentina Vaccines market, by application, 2015 - 2026 (USD Million)

  • Table MEA Vaccines market, by country, 2015 - 2026 (USD Million)

  • Table MEA Vaccines market, by type, 2015 - 2026 (USD Million)

  • Table MEA Vaccines market, by product, 2015 - 2026 (USD Million)

  • Table MEA Vaccines market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table South Africa Vaccines market, by type, 2015 - 2026 (USD Million)

  • Table South Africa Vaccines market, by product, 2015 - 2026 (USD Million)

  • Table South Africa Vaccines market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Nigeria Vaccines market, by type, 2015 - 2026 (USD Million)

  • Table Nigeria Vaccines market, by product, 2015 - 2026 (USD Million)

  • Table Nigeria Vaccines market, by application, 2015 - 2026 (USD Million)

  • Table Recent Developments & Impact Analysis, by Key Market Participants

  • Table Recent Developments & Impact Analysis, by Key Market Participants

  • Table Company market position analysis

  • Table Company Profiles

  • Table Jintan Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Kangtai Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Hissen Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table J&J(Crucell) Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Novartis(GSK) Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Sanofi Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Hualan Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table MedImmune Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table CSL Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Pfizer Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Merck Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table China National Biotec Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Tiantan Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table GSK Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

Report Purchase

reports
$4840
$9680
BUY NOWClick MeBUY NOW
top